期刊
ENDOCRINE REVIEWS
卷 39, 期 1, 页码 21-35出版社
ENDOCRINE SOC
DOI: 10.1210/er.2017-00167
关键词
-
资金
- German Research Foundation
- European Research Council
- JDRF
- European Foundation for the Study of Diabetes (EFSD)/Lilly Fellowship Programme
- European Foundation for the Study of Diabetes [Lilly FS 2017_3] Funding Source: researchfish
Hippo signaling is an evolutionarily conserved pathway that critically regulates development and homeostasis of various tissues in response to a wide range of extracellular and intracellular signals. As an emerging important player in many diseases, the Hippo pathway is also involved in the pathophysiology of diabetes on the level of the pancreatic islets. Multiple lines of evidence uncover the importance of Hippo signaling in pancreas development as well as in the regulation of beta-cell survival, proliferation, and regeneration. Hippo therefore represents a potential target for therapeutic agents designed to improve beta-cell function and survival in diabetes. In this review, we summarize recent data on the regulation of the Hippo signaling pathway in the pancreas/in pancreatic islets, its functions on beta-cell homeostasis in physiology and pathophysiology, and its contribution toward diabetes progression. The current knowledge related to general mechanisms of action and the possibility of exploiting the Hippo pathway for therapeutic approaches to block beta-cell failure in diabetes is highlighted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据